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ABSTRACT
Objectives The WHO estimates that the COVID-19 
pandemic has led to more than 1.3 million deaths (1 377 
395) globally (as of November 2020). This surge in death 
necessitates identification of resource needs and relies on 
modelling resource and understanding anticipated surges 
in demand. Our aim was to develop a generic computer 
model that could estimate resources required for end- of- 
life (EoL) care delivery during the pandemic.
Setting A discrete event simulation model was developed 
and used to estimate resourcing needs for a geographical 
area in the South West of England. While our analysis 
focused on the UK setting, the model is flexible to changes 
in demand and setting.
Participants We used the model to estimate resourcing 
needs for a population of around 1 million people.
Primary and secondary outcome measures The model 
predicts the per- day ‘staff’ and ‘stuff’ resourcing required 
to meet a given level of incoming EoL care activity.
Results A mean of 11.97 hours of additional community 
nurse time, up to 33 hours of care assistant time and up to 
30 hours additional care from care assistant night sits will 
be required per day as a result of out of hospital COVID-19 
deaths based on the model prediction. Specialist palliative 
care demand is predicted to increase up to 19 hours per 
day. An additional 286 anticipatory medicine bundles per 
month will be necessary to alleviate physical symptoms 
at the EoL care for patients with COVID-19: an average 
additional 10.21 bundles of anticipatory medication per 
day. An average additional 9.35 syringe pumps could be 
needed to be in use per day.
Conclusions The analysis for a large region in the South 
West of England shows the significant additional physical 
and human resource required to relieve suffering at the 
EoL as part of a pandemic response.
INTRODUCTION
An estimated 1 377 395 people died between 
the 30 January 2020, when the WHO Director 
General declared COVID-19 a Public Health 
Emergency of International Concern and 22 
November 2020 at the publication of their 
latest report.1 Increasingly, excess mortality 
is being used to describe the impact of 
COVID-19, comparing current mortality, with 
deaths at the same period in previous years, 
indicating deaths that are likely related to 
COVID-19 but that have not been directly 
attributed to it due, primarily, to differences 
in testing. Excess mortality also includes 
deaths due indirectly to COVID-19, resulting 
from disruptions to health services and 
health seeking because of the pandemic. 
Excess mortality in the USA from 1 February 
2020 to 25 May estimates between 84 891 and 
113 139 all- cause excess deaths.2 Cumulative 
excess mortality in the UK is estimated to be 
around 48 823 (31 January to week ending 15 
May).3 In the peak week of COVID-19 deaths 
in April in the UK, there was a 113% higher 
excess mortality compared with the same 
period in the previous 5 years.4 This surge in 
death rates is substantial and represents an 
extensive personal and societal cost, as well as 
a significant increased burden on end- of- life 
(EoL) care resource. It is essential that those 
dying from COVID-19, as with all illnesses, 
receive high- quality relief of suffering, which 
is mandated by the human right to health and 
a recognised component of essential universal 
health coverage.5 Without access to the essen-
tial palliative care package, countries will not 
meet the sustainable development goals, and 
inequity of access to quality EoL care is likely 
to increase.5 6
In COVID-19, where predominant physical 
symptoms at the EoL include delirium and 
respiratory distress,7 palliative care has a key 
role in administration of anticipatory medi-
cines. Anticipatory medication may include 
Strengths and limitations of this study
 ► Provides a step- change in end- of- life resource plan-
ning during a pandemic.
 ► Model provided free and open source to allow others 
to use and further develop.
 ► Model built collaboratively with commissioners, pro-
viders and academics.
 ► Limited data to model general practitioner and non- 
COVID-19 excess death impact.
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midazolam for agitation, morphine or equivalent opioid 
for breathlessness or pain, among others. Palliative and 
EoL care are critical in the pandemic context to support 
the psychological and spiritual needs of patients, their 
loved ones and health professionals particularly in the 
context of social isolation due to the virus. EoL care, 
defined in this paper as the last days of life, differs by 
culture, country and by setting (home, hospital, hospice 
and care home). Lower income countries frequently rely 
more on informal care networks of family and friends 
who in some care settings are supported by health profes-
sionals with an interest in palliative and EoL care and may 
not be able to access essential palliative medicines.5 High- 
income countries rely on a specialist and generalist model 
of delivery of palliative care. In the UK, generalist palli-
ative care, provided by general practitioners (GPs) and 
community nurses (also known as district nurses) working 
in peoples’ residences and care homes support EoL care 
for the majority of the population.8 Specialist palliative 
care provision varies across the UK but includes hospice 
services, hospital palliative care teams and community 
palliative care. The critical resource components of EoL 
care in any setting include multidisciplinary EoL exper-
tise (for instance physiotherapy, occupational therapy, 
doctors, nurses, healthcare assistants, spiritual care, social 
work support and psychologists), as well as availability and 
access to anticipatory medication and the delivery systems 
of those medication (eg, commonly syringe pumps in a 
UK setting). Despite increasing recognition of the impor-
tance of palliative care during the pandemic,9–11 identi-
fying the essential resource to continue the high- quality, 
equitable delivery of such care has been overlooked in 
many national responses.
Mathematical modelling allows estimation of required 
resource in the face of changing demand. It is common in 
infectious disease and acknowledged for its utility in plan-
ning and coordination for predicted surges in demand 
for healthcare resource, changing epidemiology of the 
disease and social responses to it. The model presented 
here was conceived to predict local EoL resource demand 
for the anticipated waves of COVID-19 death. It was devel-
oped in collaboration with clinicians, local health service 
funders (known as commissioners in the UK) and health 
providers and based on representative UK health data for 
a population of 968 314 in the South West of England.12 
It predicts key EoL care resources needed for a given 
level of incoming activity (dying) and duration of EoL 
care, adaptable to different geographical regions within 
the UK or other countries, and flexible, allowing users 
to include newly emerging evidence about COVID-19. 
The model is free and open source and has been made 
publicly available.
A palliative care pandemic response requires proactive 
planning around four elements: ‘staff, stuff, space and 
systems’.13 Delivering this palliative pandemic framework 
requires essential estimation of demand for EoL resources 
in each of these elements; this can be facilitated by EoL 
resource modelling and is necessary to facilitate equitable 
access to the high- quality relief of suffering essential in a 
pandemic. This study aimed to estimate the ‘stuff’, such 
as essential medication to treat common symptoms of 
breathlessness and the equipment to deliver those medi-
cations, as well as the ‘staff’, including district nurse and 
specialist palliative care input required to support quality 
care for the growing number of deaths in the community 
during the COVID-19 pandemic in the South West region 
of England.
METHODS
A conceptual model was designed in collaboration with 
practising clinicians, modelling experts and local health 
service funders and providers, including links with the 
clinical cabinet who represent local senior leaders in clin-
ical decision making. An iterative approach with two local 
palliative care doctors, email correspondence with a local 
lead district nurse (one) and the former lead of EoL care 
commissioning and current lead of the publicly funded 
National Health Service (NHS) and social care services 
(Sirona). Further stakeholder engagement was chal-
lenging during the peak of the pandemic. This collabora-
tive effort aimed to estimate essential EoL care resource 
need (approximated in ‘bundles’ of EoL resource) in the 
different settings in which it is delivered. Staff and stuff 
estimates were made based on the collaborative approach. 
Since space was not a limiting factor for the community 
care being delivered (at home), this was not specifically 
described in the model. However, the model is flexible 
to location, and therefore, future analysis with the model 
can include this feature. The systems identified as a key 
focus of palliative pandemic planning include care path-
ways to triage patients and escalate care for uncontrolled 
symptoms. We had insufficient data to make assumptions 
to include this approach in the model. The staff and stuff 
information was then used to develop a discrete event 
simulation model. Discrete event simulations are types 
of model that simulate entities flowing between discrete, 
sequential events and the resource utilisation needed to 
meet incoming levels of activity.14 Probability distributions 
are used to emulate the real- world variability observed in 
arrival and process times. The model, using the Python- 
based SimPy15 framework, is available here: https:// 
colab. research. google. com/ drive/ 1K0- xsqG_ uIpo Whw8 
6tjO UM55 OcFfhq_ 2.
Figure 1 shows an overview of the basic model struc-
ture. Patients enter the model at the point they need EoL 
care at home, in a care home or in hospital. The time 
between patients arriving into the model in each setting is 
randomly selected from an exponential probability distri-
bution and can be set to increase or decrease over time 
to account for growth or decline in activity. An exponen-
tial distribution is commonly used to model time between 
independent events occurring, such as the arrival of 
people into a system. The model allows for the capture of 
non- COVID-19 patients, but we only simulated COVID-19 
patient activity to predict excess resource need. We 
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excluded two resources from our analysis: hospital nurse 
time (which is already incorporated in hospital planning) 
and GP time (as we were unable to quantify excess GP 
time for EoL care as a result of COVID-19). Both are 
included in the model should others wish to specifically 
include them in their analyses. The important spiritual 
and psychosocial contributions (social workers and chap-
lains) of the palliative care multidisciplinary team were 
not included in the model due to limited or absent data 
for modelling.
Patients are allocated a ‘bundle’ of EoL care resources, 
each of which has a probability of being selected, and a 
duration for their EoL care, sampled from an exponen-
tial distribution. There are seven types of resource in the 
model: anticipatory medicine bundles, syringe pumps, 
community nurse time, hospital nurse time, health-
care assistant time for personal care, specialist palliative 
care time (eg, local hospice support) and GP time. The 
amount and/or frequency of each of these resources 
varies according to the level of need of patients, with 
three levels of need for patients in home and care home 
settings, and just a single level of need modelled for 
hospital patients, representing the most complex needs 
in terms of the resources we capture in the model. Antic-
ipatory medicine bundles may include a combination 
of midazolam, morphine sulphate and an antiemetic, 
but these have deliberately not been specified since the 
bundle may vary per region and the significance is that 
the drugs are generally prescribed together for EoL care, 
and therefore, they have been treated as a bundle. Staff 
resources are specified in terms of the number of ‘visits’ 
(physical or virtual) per day, the length of visits and the 
resources needed per visit. Visit lengths are sampled 
randomly for each patient from a normal distribution, in 
which most values are assumed to be close to the mean. 
The necessary resources needed over time are recorded.
The simulation can be run for a chosen length of time 
and for a chosen number of runs. This is important when 
there is randomness in the model to ensure that results 
are not solely based on runs of ‘good’ or ‘bad’ luck in 
random number selection. The model calculates results 
over runs to maximise accuracy.
To model the EoL care resource needs for Bristol, North 
Somerset and South Gloucestershire, we derived param-
eter values from a variety of local and national sources. 
Office for National Statistics data16 indicates that, from 31 
March 2020 to 3 April 2020, the total COVID-19 deaths 
recorded was 35, with 29 recorded in hospital. Govern-
ment statistics17 report 130 new cases in the locality over 
the same 4 days. Therefore, we estimate the percentage of 
patients requiring EoL care in hospital is 22.3% (29/130). 
While this is not by any means a precise estimate, not 
least due to the lag between new cases and deaths, it does 
provide us with an approximation sufficient for model-
ling, particularly given the relative ‘stability’ in cases and 
deaths around the ‘peak’ we’re modelling.
Data from Scotland18 indicate 24.6% of COVID-19 
deaths take place in care homes and 13.3% at home. If we 
are estimating 29 cases per day needing hospitalised EoL 
care, and this represents 62% of EoL cases (100%–24.6% 
in care homes and 13.3% at home), then this means that, 
for our locality, we would estimate a total of 46.8 new EoL 
cases per day across all settings, with 11.5 per day in care 
homes and 6.2 per day at home. Assuming that 22.3% of 
cases require EoL care, then we would estimate 6.47 new 
EoL care cases per day in hospital, 2.56 per day in care 
homes and 1.38 per day at home. This translates to mean 
times between arrivals of new patients in the model of 
223 min for hospital cases, 563 min for care home cases 
and 1043 min for cases at home. We modelled a stable 
mean rate of activity based on the ‘peak’ levels of activity 
observed at the time of writing.
A study of 101 patients with COVID-19 in London 
found that patients spent an average of 2 days under the 
palliative care team.7 The local palliative care team esti-
mated the community EoL care duration to be similar, 
at around 2 days for those in care homes and 3 days for 
those at home.
Figure 1 Overview of the basic structure of the model. EoL, end of life; GP, general practitioner.
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Table 1 shows an overview of the bundles of resource 
used in the model that were categorised first on the basis 
of the setting: (1) home, (2) care home (residential or 
nursing) and (3) hospital. For the ‘home’ and ‘care 
home’ settings, these bundles were further categorised 
according to three levels of need (high, medium and low) 
for palliative care support. For patients with COVID-19 
receiving EoL care at home, it was estimated that around 
25% of patients would need the highest level of care due 
to the complexity of their needs or limited functional 
status. They would typically receive two 1- hour district 
nurse contacts per day, and we assume a SD of 15 min 
around each contact time. Two care assistants visiting 
for 40 min (SD 5 min) four times per day are needed for 
personal care, as well as one care assistant on a 12- hour 
‘night sit’ every other day. Around 1 hour of specialist 
palliative care per day would be needed, along with a 
bundle of anticipatory medicines and a syringe pump to 
administer medicines.
Around 5% of patients at home have very low- level 
needs or do not want regular input. For these patients, 
anticipatory medicine bundles would still be provided, 
and a minimal level of district nurse contact, estimated at 
around 30 min every other day (SD 5 min). The remaining 
70% at home would receive one 30 min district nurse 
contact per day (SD 5 min). Three 30 min (SD 5 min) care 
assistant visits per day, and a bundle of anticipatory medi-
cines would be provided. Around half of the patients in 
this cohort require a syringe pump. Specialist palliative 
care support was estimated at around 1 hour (SD 15 min) 
every other day. Travel time was excluded from visit dura-
tion for estimates of community nurses, care assistants 
and specialist palliative care support, as travel times can 
vary widely and travel time is already considered as part of 
community care planning.19
For patients in care homes, those in residential 
homes would typically require the highest level of EoL 
care resource because of the lack of internal nursing 
support. Therefore, we used our three bundles of high- 
level, medium- level and low- level resource for care home 
patients to represent those in residential homes needing 
external support, those in nursing homes needing 
Table 1 Overview of the bundles of resource used in the model for each of the three care settings, including their frequencies 







population (home or 

















High EoL care 
need
25 Two visits 
per day 
× 1 hour 
(15 min SD)
2 CA × four 
visits per 
day × 40 min 
(5 min SD)
1 CA × 12- 
hour night sit 
every other 
day
1 hour per day 
(15 min SD)





70 One visit 
per day 
× 30 min 
(5 min SD)
1 CA × three 
visits per 
day × 30 min 
(5 min SD)
  1 hour every 
other day 
(15 min SD)
1 for duration 1 for 
duration 
for 50% of 
patients
Home
Low EoL care 
need
5 One visit 
every 
other day 
× 30 min 
(5 min SD)






17.3 Two visits 
per day 
× 1 hour 
(15 min SD)
    1 hour per day 
(15 min SD)






22.7       1 hour per day 
(15 min SD)




nursing, low EoL 
care need)
60 One visit 
every 
other day 
× 30 min 
(5 min SD)
      1 for duration   
Hopsital 100         1 for duration 1 for 
duration
EoL, end of life.
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external support and those in either nursing or residen-
tial homes who have very low level needs, respectively. In 
addition, we would expect to see more patients needing 
EoL care in nursing homes due to the complexity of 
their care needs. A non- weighted mean calculation from 
2011 Census data shows an approximate 50/50 split 
between nursing and residential home residency in the 
locality.20 A prior study reported 41 969 annual deaths in 
nursing homes, compared with 32 138 deaths in residen-
tial homes.21 This represents a 31% higher death rate in 
nursing homes, assuming population levels are the same. 
The Clinical Commissioning Group (CCG) estimated 
around 40% of care home residents require non- trivial 
external EoL care support. If the nursing home cohort is 
31% larger, we estimate that 17.3% of patients fit into the 
‘residential home – external support required’ bundle 
and 22.7% into the ‘nursing home – external support 
required’ bundle.
For those in a residential home needing external 
support, two 1- hour district nurse contacts and 1- hour 
specialist palliative care support (15 min SD) would be 
required per day. These patients would also be supplied 
with a bundle of anticipatory medicines and a syringe 
pump. Patients in a nursing home would only need 
district nurse support to answer short ad hoc queries over 
the phone, so we exclude them from this bundle. Patients 
with low level needs would only require a bundle of antic-
ipatory medicines, and minimal district nurse contact, 
estimated at around 30 min (SD of 5 min) every other day.
Patients receiving EoL care in hospital would receive 
their nursing and personal care support via the hospital 
staff, and so the only external resources required would 
be syringe pumps and bundles of anticipatory medicines.
We ran the model for a simulated 28 days in each model 
run. The model was allowed to ‘warm up’ for 5 days of 
simulated time, because the model starts with no patients 
in the system, which is not a realistic representation. 
Therefore, we allow the model to run for a 5- day period 
before we start collecting results to ensure we are not 
underestimating needs at the start of a model run. The 
model was run 100 times, and average results were taken 
across the batch of runs.
 




The model predicts that up to 28 hours of additional 
district nurse time (mean of 11.97 hours, 0.18 hours 
SE) will be required per day because of out- of- hospital 
COVID-19 deaths. Ninety- five per cent of days are 
predicted to need no more than 19 hours of additional 
district nurse time and 5% of days would need less than 
5.7 hours. Up to 33 hours of care assistant time would be 
required per day (mean 9.17 hours, 0.23 hours SE), with 
95% of days needing no more than 19 hours but only 
5% days needing less than 2 hours. In addition, up to 
30 hours of additional care from night sits per 24- hour 
period may be required (mean of 5.74 hours per day, 
0.22 hours SE), with 95% of 24 hour periods requiring no 
more than 17 hours and around 26% of nights needing 
no night sit resource.
Specialist palliative care demand is predicted to 
increase up to 19 hours per day (mean of 9.32 hours 
per day, 0.12 hours SE). Ninety- five per cent of days are 
predicted to need no more than 14 hours, but only 5% of 
days would need less than 5 hours.
Stuff
Physical resource demand will increase by an additional 
286 anticipatory medicine bundles or ‘just in case’ 
prescriptions per month because of demand for EoL care 
for patients with COVID-19 both in the community and 
in hospital. This represents an average additional 10.21 
bundles (0.06 SE) of anticipatory medication per day, 
with a predicted minimum and maximum of 2 and 23 
bundles per day, respectively. Ninety- five per cent of days 
are predicted to need no more than 16 bundles, but only 
5% of days would need less than five bundles.
For syringe pumps, an average additional 9.35 pumps 
(0.11 SE) would be needed to be in use per day, with a 
predicted minimum and maximum of 1 and 20 pumps 
in use per day, respectively. Ninety- five per cent of days 
are predicted to need no more than 15 pumps in use, but 
only 5% of days would need less than five pumps in use.
Figures 2 and 3 show the model’s predicted mean 
resource usage per day for each of 28 days in the model 
for ‘staff’ and ‘stuff’ resources, respectively, averaged 
across the 100 runs in the trial. Error bars show SEs of the 
mean across the runs in the trial.
Figure 2 Predicted mean staff hours required per day 
across the 100 runs of 28 days of the simulation for 
community nurses, night sits, care assistants (CAs) and 
specialist palliative care.
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An increase in community nurse, care assistant, specialist 
palliative care time and anticipatory medicine and syringe 
driver resource is predictable with the rise in deaths due 
to COVID-19. The significance of this model is in quan-
tifying that rise across a population of nearly 1 million 
in the UK to demonstrate the importance of planning 
and preparation for EoL care resource need during 
a pandemic. With an average of 12 hours extra district 
nurse time and 9 hours of additional care assistant time 
per day, care clearly cannot be met with current staffing 
levels, let alone with anticipated staff absence due to 
sickness, household isolation, other caring responsibili-
ties and with a rise in non- COVID-19 deaths as has been 
demonstrated worldwide.2 4
Based on the model analysis for additional COVID-19 
EoL care need, specialist palliative care demand is 
predicted to increase by around 9 hours per day. This 
will necessitate different ways of working. Two hundred 
and eighty- six additional anticipatory medicine bundles 
or ‘just in case’ prescriptions predicted to be needed 
per month due to COVID-19 EoL care, which in the UK 
context cannot be reused even if they are not used by the 
named patient, may risk specific drug shortages. Nine 
additional syringe pumps needing to be in use per day 
at a cost of around £1742 each or £15 678 in total is also 
a significant added resource demand for EoL care for 
patients with COVID-19 in the community. Nine syringe 
pumps are also only the average in use in a 24- hour period 
and to ensure demand is met 95% of the time, 15 would 
be required, at a total cost of £26 130.
Comparison with the literature
To our knowledge, this is the first published model of EoL 
resource need during the COVID-19 pandemic worldwide. 
Understanding demand for resource to relieve serious 
health- related suffering at the EoL is critical in providing 
essential solace to patients in knowing they are not aban-
doned, with care provided up to death and beyond for 
their families. Palliative care is important to mitigate the 
moral distress in health professionals who may be in the 
unenviable position of triaging patients to palliative care 
support where limited intensive care support may be 
available.22 Palliative care is consistently shown to reduce 
symptom burden at the EoL and improve bereavement 
outcomes for families.23 24 Planning for the predicted 
surge in demand follows the Downar and Seccareccia 
pandemic plan13 identifying ‘stuff’, such as ensuring suffi-
cient anticipatory medication and syringe pumps (and 
subcutaneous butterflies) availability, and acknowledging 
the minimum specialist and generalist palliative care 
staff required to fufill our duty of care, alleviating serious 
health related suffering. In many countries, like the UK, 
EoL community data are challenging to obtain because 
the community setting crosses different health and social 
care partnerships, as well as third sector charitable organ-
isations. It is hardly surprising, therefore, that the clear 
increased risk in terms of acquisition and survival from 
COVID-19 to those who live in care homes was recognised 
late, and appropriate allocation of resources was hindered 
in the UK.25
Community- driven carer injectable drug administration 
policies,26 intended to provide symptom relief and access 
to medication even where there may be staff shortages, 
is one solution introduced in this locality to address the 
predicted staff shortages. Rapid generation of national 
and local guidelines on topics such as advance care plan-
ning, communication in COVID-19, EoL symptom care 
and bereavement support can and have been delivered 
remotely using digital solutions, demonstrating the large- 
scale collaborative efforts through national and interna-
tional organisations27 28 that are possible to upskill other 
health professionals and mitigate the capacity constraint 
of specialist palliative care. Anticipating the large increases 
in demand in anticipatory medication and syringe pumps 
has also contributed to innovative community solutions, 
such as altered prescribing behaviour to prevent drug 
shortages and a greater reliance on butterfly needles to 
administer subcutaneous injections.
Strengths and limitations
This model is a step change in planning for EoL care 
during the COVID-19 pandemic and provides detail for 
the stuff, staff, space and systems pandemic planning 
approach. It has been made freely available to enable 
modellers and health service funders to estimate need 
for EoL resource in different regions, countries and for 
different rates of disease and resource estimations for 
usual care. The model also highlights the gaps and oppor-
tunities for research in EoL care in the community. The 
work was undertaken collaboratively with health service 
funders, providers, clinicians and modellers to base 
assumptions in the reality of current practice during the 
pandemic.
Figure 3 Predicted mean anticipatory medicine and syringe 
pump usage per day across the 100 runs of 28 days of 
the simulation. Anticipatory medicine numbers represent 
numbers of new bundles required per day, while syringe 
pump numbers represent total needed to be in simultaneous 
use per day.
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Some of the limitations of the model assumptions are 
limitations due to available data, rather than of the model 
per se. The rate of COVID-19 death in the community 
setting is based on the latest available figures at the time of 
the project, and where those for England were absent, the 
most geographically similar area available, Scotland, was 
inputted. While all deaths from COVID-19 are a tragedy, 
it has been postulated that between 5% and 15% of 
COVID-19 deaths may have occurred in people who would 
have died of other causes within the year.29 However, even 
if this was the case and that all deaths from COVID-19 do 
not represent additional resource and only 85% extra is 
required, the increased demand of COVID-19 deaths has 
occurred acutely, rather than spread out over the longer 
time period of a year, and therefore the supply constraint 
is still very problematic. The model does not take into 
account excess mortality, which has not been attributed 
directly to COVID-19. In other words, those deaths that 
have erroneously not been identified as COVID-19 due 
to absent testing, or deaths that have taken place because 
usual care has been disrupted leading to delayed health-
care presentation or interrupted local management of 
illness. When comparing the observed deaths in the UK 
for March and April with the expected number of deaths 
for the same period, based on the average deaths usually 
occurring in that time (over a 5- year period), it is clear 
that deaths due to COVID-19 are significantly increased, 
but deaths that are not being directly attributed to 
COVID-19 have also risen significantly.3 While many of 
the non- COVID-19 deaths may in reality be unconfirmed 
COVID-19 deaths, the flexibility of the model will allow 
more accurate resource estimations to provide for palli-
ative and EoL care to be made with improved data over 
time, and this will become the focus of further work.
While we would have liked to have included the 
resource requirement for EoL care in the commu-
nity for non- COVID-19 deaths and to compare current 
observed practice with expected practice based on 
historic evaluation, the resource data were too limited, 
and in the first instance, we have focused on the deaths 
from COVID-19. Similarly, inclusion of GP time is felt to 
be of high importance, but data on time spent by GPs 
on EoL care are limited and worthy of further research 
given the significant role they play in the care of those 
at the EoL in the community. Hospice inpatient services 
have also not been included in this analysis (although 
the model could easily accommodate their inclusion). 
This is because hospice was treated as a finite resource, 
which was not affected by the pandemic in that there are 
limited numbers of inpatient hospice beds. For instance, 
in our locality, there are 25 inpatient beds, and only one 
patient has been confirmed to have died with COVID-19 
in a hospice setting. Increased community support via 
redeployment of hospice health professionals to tele-
phone advice lines was accounted for in the analysis as 
a specialist palliative care resource. Personal protective 
equipment has not been included in the model. Potential 
COVID-19 changes to the anticipatory care bundle, such 
as more carer- administered drugs (eg, lay carer adminis-
tration of injectable medication or increased prescribing 
of non- injectable medication to mitigate staffing short-
ages), were not included in the analysis in order to model 
the care that most clearly mirrors that which is deemed 
optimal practice. Further consultation with a Delphi or 
other consensus building process or field data to ensure 
the robustness of estimates on staff and stuff would be 
encouraged to make the model most accurately reflect 
the setting in which it is applied. Finally, we have not 
included ‘travel time’ for community nurses and carers; 
therefore, in more rural settings, this will change esti-
mates, which the model can accommodate. Models can 
be retrospectively validated and adapted once data of the 
impact matures.
Implications for practice
Our cultural bias towards healthcare heroics risks over-
looking the essential contribution of palliative and 
EoL care to a pandemic. Armed with the structure to 
outline palliative care pandemic planning,13 this study 
allows realistic modelling of the essential ingredients 
to prepare, plan and deliver a palliative care pandemic 
response tailored to local work patterns and resource. 
Without anticipating the resource constraints, equitable 
care is compromised. This pandemic is a reminder of the 
vital need for collaborative, flexible working and quality 
data collection to inform preparation and planning to 
prevent deaths with physical and psychosocial distress. 
There is limited evidence on cost- effectiveness of palli-
ative care overall,30–32 with research complicated by the 
heterogeneity of specialist palliative care services in the 
UK.33 During the pandemic, we have found no evaluation 
comparing the financial cost of care for those affected 
who do and do not receive palliative care, and this is an 
area that requires greater research and understanding. 
Emphasising EoL care does not negate the importance 
of life- saving or even life- sustaining care but acknowl-
edges the moral imperative to provide care for everyone 
in a pandemic, even where a cure is not possible. The 
model presented here provides evidence of the predicted 
resource essential to provide quality palliative care during 
a pandemic.
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